Navigation Links
Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
Date:10/25/2010

PRINCETON, N.J., Oct. 25 /PRNewswire-FirstCall/ -- Soligenix, Inc. (Soligenix or the Company) (OTC Bulletin Board: SNGX), a late-stage biopharmaceutical company, today reported preliminary results from its Phase 2 "proof-of-concept" exploratory clinical trial of orBec® for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.  The preliminary results indicate that orBec® appears safe and well tolerated in this patient population, but did not achieve statistical significance in the primary endpoint, which was the proportion of subjects who developed acute GVHD with severity sufficient to require systemic immunosuppressive treatment on or before day 90 after transplantation.  However, an encouraging result was that use of orBec® resulted in fewer cases of more severe acute GVHD grades IIb-IV (21% vs. 33% of patients receiving placebo), although this difference was not statistically significant.  This result has the potential to be clinically relevant because GVHD grades IIb-IV are associated with more severe disease involving the skin and liver as well as being associated with poorer outcomes, including mortality rates that approach 100% in the grade IV patient population.  Further analysis of the complete dataset continues and is aimed at identifying other potential effects seen with orBec® in preventing acute GVHD.

The Phase 2 prevention study was a randomized, double-blind, placebo-controlled trial that enrolled 140 patients who had been randomized to either orBec® or placebo at a 2:1 ratio.  Prior to HCT, patients began study drug at the start of their conditioning regimen and continued through day 75 following HCT. The study was con
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
2. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
3. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
4. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
5. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
6. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
7. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
8. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
9. Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... YORK , Nov. 24, 2014  AiCure, ... and motion-sensing technology to monitor medication ingestion, has ... to monitor and intervene with patients receiving medication ... Fatal overdoses from prescription opiates have quadrupled ... more deaths per year than heroin, cocaine and ...
(Date:11/24/2014)... , Nov. 24, 2014  Rigel Pharmaceuticals, Inc. (Nasdaq: ... is retiring from the board of directors and from ... Raul Rodriguez , most recently serving as the company,s president ... executive officer and join the board of directors.  Gary ... 2005, will become chairman. Mr. Gower is expected to remain ...
(Date:11/24/2014)... PLYMOUTH MEETING, Pa. , Nov. 24, 2014  Inovio ... Dr. J. Joseph Kim , President and CEO of ... board and management team to ring the Nasdaq Opening Bell ... celebration of Inovio,s September 15 th listing on the ... bell ringing ceremony, Dr. Kim said, "We are honored to ...
Breaking Medicine Technology:Can artificial intelligence solve the $55 billion problem of opioid abuse? 2Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3
... Taylor Strategy Partners (TSP), who enable clients in the life science ... organizations, is pleased to announce the expansion of its operations to ... is headquartered in Columbus, OH with additional offices in New York, ... Director, will be taking the lead of the Kansas City office. ...
... Friday, June 10, 2011 at twelve o,clock noon, NMT ... Joseph F. Finn, Jr., C.P.A. ("Finn") of the firm ... the benefit of NMT Medical creditors. ... that designed, developed, manufactured and marketed proprietary implant technologies ...
Cached Medicine Technology:Taylor Strategy Partners Set to Open Office in Kansas City in June 2011 2NMT Medical, Inc. Sealed Bid Sale of its Intellectual Property to Take Place Friday, June 10, 2011 at Twelve O'Clock Noon 2
(Date:11/24/2014)... Francisco, California (PRWEB) November 24, 2014 ... reach USD 6.19 billion by 2020, according to ... Increasing incidence rates of cardiac arrhythmias clubbed with ... drivers of this market. Though still in the ... a significant rise in usage rates in the ...
(Date:11/24/2014)... 2014 Volpara Solutions announced today ... the 100th Annual Meeting of the Radiology Society ... (RSNA Booth 1752 – South Hall). Volpara Solutions ... the rest of its innovative suite of quantitative ... enable personalized measurements of volumetric density, patient-specific dose, ...
(Date:11/24/2014)... November 24, 2014 Residents of retirement ... in this year’s SENIORS GOT TALENT, an annual online ... From piano players to classic crooners, to seniors partying ... older adults are indeed living young. , “SENIORS GOT ... there’s a cash prize, has always been about highlighting ...
(Date:11/24/2014)... Olaparib functions as a chemical of ... one of the first PARP inhibitors. Sufferers with BRCA1/2 ... of melanoma, and are often immune to other types ... malignancies a exclusive weaknesses, as the tissues of melanoma ... and allow them to proceed splitting. This implies that ...
(Date:11/24/2014)... The Holiday Inn Westbury - Long Island ... Association to donate various items consisting of practical, ... such items.The Association's program is aimed toward helping over ... nursing homes, assisted living facilities and nursing homes. The ... of seniors throughout the Long Island area. The Holiday ...
Breaking Medicine News(10 mins):Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 2Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 3Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 4Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 2Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 3Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 3Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 2Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 3Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 4Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3
... available in Spanish . Researchers headed ... New York and by Mara Macas at the Institute for ... by which some proteins that are essential for life, called ... fruit of three years of intense work, the study reports ...
... Institute (JASRI) have successfully produced a first beam of ... This light was created using SACLA, a cutting-edge X-ray ... February 2011 in Harima, Japan. SACLA (SPring-8 Angstrom Compact ... of atoms and molecules at a level of detail ...
... By Alan Mozes HealthDay Reporter , THURSDAY, June ... exercise habits of America,s teens, new data from the U.S. ... picture. Not only are high school kids guzzling far ... the CDC research team found. In fact, just one ...
... steady reduction in overall cancer death rates translates to ... 1990 and 2007, according to the latest statistics from ... 2011, and its companion consumer publication Cancer Facts & ... segments of the population equally. A special section of ...
... A team of social scientists and medical and nursing ... has pinpointed how a programme, which ran in more ... reduced the rates of potentially deadly central line bloodstream ... patient safety programmes. Funded in part by the ...
... Child Development (e-publication ahead of print) finds ... lead to a mathematical learning disability and difficulty in ... just one cause of math learning disabilities, according to ... Kennedy Krieger Institute. Approximately 6 to 14 percent ...
Cached Medicine News:Health News:Discovery of a new mechanism of gene control that is associated with cancer 2Health News:First X-ray lasing of SACLA 2Health News:High School Kids Get Too Many Sugary Drinks, Too Little Exercise: CDC 2Health News:High School Kids Get Too Many Sugary Drinks, Too Little Exercise: CDC 3Health News:American Cancer Society report finds continued progress in reducing cancer mortality 2Health News:American Cancer Society report finds continued progress in reducing cancer mortality 3Health News:American Cancer Society report finds continued progress in reducing cancer mortality 4Health News:International team works out secrets of one of world's most successful patient safety programs 2Health News:International team works out secrets of one of world's most successful patient safety programs 3Health News:Poor 'gut sense' of numbers contributes to persistent math difficulties 2Health News:Poor 'gut sense' of numbers contributes to persistent math difficulties 3
Standard general retractor system. Fully-adjustable to maintain a low profile in any approach and any patient. Blades can be stacked on top of each other in the operative site....
These retractors are packaged singly ready for sterilization at your facility....
... a revolutionary motorized electronic pipette. Conceived ... Pipetman Concept features exclusive multifunction characteristics ... one of its kind in the ... from Gilson, this product will maximize ...
... 3 - Vivid family system designed to ... cardiovascular performance, and offer an even wider ... and the OR. , ,From color flow ... connectivity, the new Vivid 3 offers a ...
Medicine Products: